Message #2 From:
Stock News Bot Date: August 19, 2005 05:47:00 AM
CLRI News Clearant, Inc. Comments on Recent Stock Activity
LOS ANGELES--(BUSINESS WIRE)--Aug. 19, 2005--Clearant, Inc. (OTCBB: CLRI), the developer of the patent protected CLEARANT PROCESS(R) for pathogen inactivation, commented today on the recent volatility in its stock price. The Company knows of no business condition or other reason to explain the recent decline in the price of its stock.
About Clearant, Inc.
Clearant, Inc., a biotechnology company headquartered in Los Angeles, California, is a leader in pathogen inactivation for biological products. Clearant, Inc. has developed the patent protected CLEARANT PROCESS(R), designed to substantially reduce all types of pathogens in biological products while maintaining a high degree of the underlying protein. Various sterilization methods on the market today only kill specific types of pathogens, such as bacteria or lipid-enveloped viruses, for specific products. The CLEARANT PROCESS(R) can substantially reduce all types of pathogens for products across many market segments including plasma proteins, tissue implants, recombinant products and blood products, and can be applied at various stages of product processing/manufacturing, including in the final container.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the biotechnology industry, and additional risks discussed in the company's filings with the SEC.
For more information about Clearant, Inc., please see www.clearant.com.
